Skip to main content
. Author manuscript; available in PMC: 2018 Jan 17.
Published in final edited form as: Osteoporos Int. 2011 Sep 1;23(4):1399–1413. doi: 10.1007/s00198-011-1728-5

Table 3.

Runx2-responsive genes related to osteoclastogenesis

Gene name p value Fold change
Day 1 Day 2
Hey1 4.1E−10 8.5 10.2
Ltc4s, Leukotriene C4 synthase 4.1E−10 8.1 7.2
Tnc, Tenascin c 1.4E−09 6.7 6.0
Apcdd1, Adenomatosis polyposis coli downregulated 1 5.0E−06 2.7 5.0
Sema7a, Semaphorin 7A 1.2E−07 4.6 4.7
Cdk5r1, Cyclin-dependent kinase 5, regulatory subunit (p35) 1 1.3E−07 2.8 4.4
Efnb1, EphrinB1 1.3E−06 2.5 2.9
Sema6b, Semaphorin6B 0.04271 −1.4 −1.5
Sema3f, Semaphorin3 F 1.2E−06 −2.1 −2.4
Sema3a, Semaphorin 3A 1.2E−07 −2.8 −2.4
OPG,Tnfrsf11b, Osteoprotegerine 4.1E−09 −3.4 −3.3
Il1rn, Interleukin 1 receptor antagonist 0.00015 −3.2 −3.9
Npr3, Natriureticpeptide receptor 3 1.2E−07 −3.7 −4.8
Ogn, Osteoglycin 4.1E−10 −4.1 −4.9
Clec2d, Ocil,C-type lectin domain family 2, member d 4.8E−07 −5.0 −6.1
Rspo2, R-spondin 2 homolog (Xenopus laevis) 4.2E−08 −4.9 −6.1
Slco2b1, Solute carrier organic anion transporter family, 2b1 4.5E−06 −3.8 −6.3

Fold change refers to average gene expression in Dox-treated versus control cultures (n=4). Negative values represent downregulation by Dox. Statistical significance (p values) was calculated for the changes on days 1 and 2 combined